Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMISULPRIDE vs AMLODIPINE\ATORVASTATIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AMISULPRIDE vs AMLODIPINE\ATORVASTATIN: Safety Overview

Metric AMISULPRIDE AMLODIPINE\ATORVASTATIN
Total FAERS Reports 3,152 636
Deaths Reported 324 44
Death Rate 10.3% 6.9%
Hospitalizations 1,537 133
Average Patient Age 42.7 yrs 69.5 yrs
% Female Patients 41.3% 59.0%
FDA Approval Date Feb 26, 2020 N/A
Manufacturer Acacia Pharma Ltd N/A
Route INTRAVENOUS N/A
Marketing Status Prescription N/A